Colgate-Palmolive Company (CL)
NYSE: CL · IEX Real-Time Price · USD
97.05
+1.16 (1.21%)
Jul 5, 2024, 4:00 PM EDT - Market closed
Colgate-Palmolive Company Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for CL stock have an average target of 94.88, with a low estimate of 84 and a high estimate of 109. The average target predicts a decrease of -2.24% from the current stock price of 97.05.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CL stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 8 | 8 | 8 | 8 | 9 | 9 |
| Buy | 4 | 4 | 4 | 4 | 4 | 5 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 15 | 15 | 15 | 15 | 16 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Exane BNP Paribas | Exane BNP Paribas | Buy Initiates $109 | Buy | Initiates | $109 | +12.31% | Jun 24, 2024 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $101 → $103 | Buy | Maintains | $101 → $103 | +6.13% | May 28, 2024 |
| Argus Research | Argus Research | Strong Buy Maintains $97 → $107 | Strong Buy | Maintains | $97 → $107 | +10.25% | May 15, 2024 |
| Barclays | Barclays | Hold Maintains $84 → $85 | Hold | Maintains | $84 → $85 | -12.42% | Apr 30, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $90 → $92 | Hold | Maintains | $90 → $92 | -5.20% | Apr 29, 2024 |
Financial Forecast
Revenue This Year
20.82B
from 19.46B
Increased by 6.98%
Revenue Next Year
21.66B
from 20.82B
Increased by 4.06%
EPS This Year
3.63
from 2.77
Increased by 31.11%
EPS Next Year
3.95
from 3.63
Increased by 8.80%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 21.6B | 22.9B | 24.0B | 24.5B | 25.6B |
| Avg | 20.8B | 21.7B | 22.6B | 23.5B | 24.4B |
| Low | 19.6B | 20.0B | 20.7B | 22.0B | 22.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.2% | 9.8% | 10.6% | 8.5% | 9.4% |
| Avg | 7.0% | 4.1% | 4.3% | 3.8% | 3.9% |
| Low | 0.8% | -3.9% | -4.4% | -2.7% | -2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.79 | 4.26 | 4.71 | 4.85 | 5.19 |
| Avg | 3.63 | 3.95 | 4.30 | 4.67 | 5.00 |
| Low | 3.40 | 3.66 | 3.93 | 4.39 | 4.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.8% | 17.4% | 19.3% | 12.8% | 11.2% |
| Avg | 31.1% | 8.8% | 8.9% | 8.5% | 7.2% |
| Low | 22.8% | 0.6% | -0.5% | 2.1% | 1.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.